Ra Medical (NYSE:RMED) said yesterday that its initial public offering brought in more than $86 million by the time it closed, including an underwriter’s option that added some $10 million to the take. The $17-per-share flotation of 4.5 million shares was bolstered by the 585,000-share over-allotment, for gross proceeds of $86.2 million. Carlsbad, Calif.-based Ra Medical, which makes the […]
Ra Medical
Ra Medical prices up-sized $66m IPO
Ra Medical yesterday priced an initial public offering worth more than $66 million, significantly higher than the range it indicated last week. The Carlsbad, Calif.-based company said Sept. 17 that it planned to float 3.3 million shares at $14 to $16 apiece, for gross proceeds of $46.7 million to $53.3 million. At the midpoint the flotation […]
Ra Medical sets range for $50m IPO
Ra Medical yesterday set the terms for its forthcoming initial public offering, which would fetch $50 million at the midpoint. The Carlsbad, Calif.-based company said it plans to float 3.3 million shares at $14 to $16 apiece, for gross proceeds of $46.7 million to $53.3 million. At the midpoint the flotation would gross $50.0 million, according […]
Ra Medical re-ups $86m IPO registration
Ra Medical has re-upped its registration for an upcoming initial public offering looking to bring in approximately $86.3 million, according to a recently posted SEC filing. Ra Medical produces the Dabra atherectomy catheter laser designed to treat patients with peripheral artery disease. The system is designed to destroy arteriosclerotic blockages through the use of radiation […]
Ra Medical registers for $87m IPO
Ra Medical yesterday registered for an initial public offering worth up to $86.5 million, according to a recently posted SEC filing. The Carlsbad, Calif.-based company said it plans to list on the New York Stock Exchange under the symbol “RMED,” according to the SEC posting. Piper Jaffray and Cantor Fitzgerald are acting as joint book runners […]
Ra Medical raises $60m
Ra Medical has raised approximately $60.2 million in a new round of financing, according to recently posted SEC filings. A total of seven unnamed investors participated in the Carlsbad, Calif.-based company’s option-based funding round, with the first sale noted on June 4, according to the filing. The company is not seeking any further funding in the […]
Ra Medical raises $18m
Ra Medical has raised $18.3 million in a new round of equity financing, according to a recently posted SEC filing. Money in the round came from 49 unnamed investors, according to the filing, with the first sale recorded last September. The Carlsbad, Calif.-based company is still seeking an additional $718,000 in the offering, according to […]
Medin Technologies taps Donaldson as CEO | Personnel Moves – April 25, 2017
Medin Technologies said last week it tapped Bill Donaldson as its new chief executive officer, replacing Andy Novotny who is resigning from his position at the head of the company. Prior to joining Medin Technologies, Donaldson served as president of Jeld-Wen Canada, leading the business unit during its parent company’s initial public offering, Totowa, N.J.-based […]
Ra Medical co-founder Burstein touts innovation, planning and caring as keys to success for medtech execs
This year has been an exciting one for Ra Medical, maker of the Dabra arteriosclerosis laser designed to treat peripheral artery disease. In May, the Carlsbad, Calif.-based company received a nod from the FDA for the Dabra, clearing it for sale in the US – something it had applied for approximately three years prior. And in September, […]
Ra Medical looks to raise $15m
Ra Medical is looking to raise $15 million, having already raised $650,000 in a new round of equity financing, according to an SEC filing posted this week. Funds already raised in the round came from 3 anonymous investors, with the 1st sale noted on September 5, according to the filing. The company has not yet […]
Ra Medical CEO Irwin aims for Feb 2018 IPO
In May, Ra Medical received a nod from the FDA for its Dabra arteriosclerosis laser, clearing it for use in the US. It was a decision the company had been waiting on for approximately 3 years, CEO Dean Irwin told MassDevice.com in an interview, and signaled a significant shift forward. “In 2014, we submitted to the FDA, […]